International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Compulsory Maintenance Treatment Program Amongst Iranian Injection Drug Users and Its Side Effects

Sharareh Eskandarieh 1 , Firoozeh Jafari 2 , Somayeh Yazdani 1 , Nazanin Hazrati 1 and Mohammad Bagher Saberi-Zafarghandi 3 , *
Authors Information
1 Bureau of Mental, Social Health and Addiction, Ministry of Health, Treatment and Medical Education, Tehran, IR Iran
2 Substance Abuse and Dependency Research Centre, Social Welfare and Rehabilitation Sciences University, Tehran, IR Iran
3 Tehran Institute of Psychiatry, School of Behavioral Sciences and Mental Health, Iran University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of High Risk Behaviors and Addiction: December 01, 2014, 3 (4); e21765
  • Published Online: September 17, 2014
  • Article Type: Brief Report
  • Received: July 4, 2014
  • Revised: July 27, 2014
  • Accepted: August 20, 2014
  • DOI: 10.5812/ijhrba.21765

To Cite: Eskandarieh S, Jafari F, Yazdani S, Hazrati N, Saberi-Zafarghandi M B. Compulsory Maintenance Treatment Program Amongst Iranian Injection Drug Users and Its Side Effects, Int J High Risk Behav Addict. 2014 ; 3(4):e21765. doi: 10.5812/ijhrba.21765.

Copyright © 2014, Zahedan University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Watson H, Munro A, Wilson M, Kerr S, Godwin J. World Health Organization, The involvement of nurses and midwives in screening and brief interventions for hazardous and harmful use of alcohol and other psychoactive substances. 2010;
  • 2. Daneshparvar HR, Sardari F, Esfahanizadeh N. A survey on substance abuse related deaths referred to Tehran's Legal Medicine Organization during 2007 and 2008. Acta Med Iran. 2011; 49(6): 383-9[PubMed]
  • 3. Parker J, Jackson L, Dykeman M, Gahagan J, Karabanow J. Access to harm reduction services in Atlantic Canada: implications for non-urban residents who inject drugs. Health Place. 2012; 18(2): 152-62[DOI][PubMed]
  • 4. Pauly B, Goldstone I, McCall J, Gold F, Payne S. The ethical, legal and social context of harm reduction. Can Nurse. 2007; 103(8): 19-23[PubMed]
  • 5. Giacomuzzi SM, Ertl M, Kemmler G, Riemer Y, Vigl A. Sublingual buprenorphine and methadone maintenance treatment: a three-year follow-up of quality of life assessment. ScientificWorldJournal. 2005; 5: 452-68[DOI][PubMed]
  • 6. Kheirandish P, SeyedAlinaghi S, Jahani M, Shirzad H, Seyed Ahmadian M, Majidi A, et al. Prevalence and correlates of hepatitis C infection among male injection drug users in detention, Tehran, Iran. J Urban Health. 2009; 86(6): 902-8[DOI][PubMed]
  • 7. Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct J. 2012; 9: 18[DOI][PubMed]
  • 8. Deng Q, Tang Q, Schottenfeld RS, Hao W, Chawarski MC. Drug use in rural China: a preliminary investigation in Hunan Province. Addiction. 2012; 107(3): 610-3
  • 9. Topp L, Iversen J, Baldry E, Maher L. Housing instability among people who inject drugs: results from the Australian needle and syringe program survey. J Urban Health. 2013; 90(4): 699-716[DOI][PubMed]
  • 10. Obot IS, Anthony JC. Association of school dropout with recent and past injecting drug use among African American adults. Addict Behav. 1999; 24(5): 701-5[PubMed]
  • 11. Fernandez Miranda J, Gonzalez Garcia-Portilla M, Saiz Martinez P, Gutierrez Cienfuegos E, Bobes Garcia J. [Influence of psychiatric disorders in the effectiveness of a long-term methadone maintenance treatment]. Actas Esp Psiquiatr. 2001; 29(4): 228-32[PubMed]
  • 12. Islam MM, Day CA, Conigrave KM. Harm reduction healthcare: from an alternative to the mainstream platform? Int J Drug Policy. 2010; 21(2): 131-3[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments